| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
44,896 |
39,956 |
$950K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,794 |
8,957 |
$342K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,792 |
1,623 |
$141K |
| 62323 |
|
753 |
711 |
$79K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,785 |
2,503 |
$36K |
| 64493 |
|
387 |
336 |
$35K |
| 64635 |
|
133 |
105 |
$24K |
| 64494 |
|
380 |
317 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
245 |
236 |
$12K |
| 64636 |
|
118 |
93 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
943 |
812 |
$3K |
| 20610 |
|
58 |
54 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
314 |
282 |
$1K |
| G9500 |
Radiation exposure indices documented in final report for procedure using fluoroscopy |
457 |
386 |
$649.88 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
91 |
86 |
$617.72 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
507 |
460 |
$484.49 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
56 |
46 |
$0.07 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,297 |
1,180 |
$0.03 |
| 1124F |
|
1,141 |
1,055 |
$0.01 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
577 |
540 |
$0.00 |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
155 |
122 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
577 |
538 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
189 |
168 |
$0.00 |
| 1123F |
|
151 |
123 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
353 |
310 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
355 |
331 |
$0.00 |
| G9717 |
Documentation stating the patient has had a diagnosis of bipolar disorder |
55 |
45 |
$0.00 |
| 1036F |
|
21 |
18 |
$0.00 |